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Rho family GTPases are critical regulators in determining and maintaining cell polarity. In Saccharomyces
cerevisiae, Rho3 and Cdc42 play important but distinct roles in regulating polarized exocytosis and overall
polarity. Cdc42 is highly polarized during bud emergence and is specifically required for exocytosis at this
stage. In contrast, Rho3 appears to play an important role during the isotropic growth of larger buds. Using
a novel monoclonal antibody against Rho3, we find that Rho3 localizes to the cell surface in a dispersed pattern
which is clearly distinct from that of Cdc42. Using chimeric forms of these GTPases, we demonstrate that a
small region at the N terminus is necessary and sufficient to confer Rho3 localization and function onto Cdc42.
Analysis of this domain reveals two essential elements responsible for distinguishing function. First, palmi-
toylation of a cysteine residue by the Akr1 palmitoyltransferase is required both for the switch of function and
the switch of localization properties of this domain. Second, two basic residues distal to the palmitoylation site
are required for regulating binding affinity with the Exo70 and Sec3 effectors. This demonstrates the impor-
tance of localization and effector binding in determining how these GTPases evolved specific functions at
distinct stages of polarized growth.
Cell polarity is a highly conserved feature of eukaryotic cells
and is important for a number of events in animal cell biology,
including embryonic development, cell migration, and epithe-
lial function (21). The budding yeast Saccharomyces cerevisiae
provides a simple model system in which to understand cell
polarity, as much of the machinery that is responsible for
polarity between yeast and animal cells is highly conserved.
Rho/Cdc42 family GTPases are examples of this conservation
and have been shown to be critical determinants of polarity in
both yeast and animal cells. Rho GTPases are thought to exert
their effects on cell polarization through regulation of a num-
ber of cellular processes, including the cytoskeleton and polar-
ized delivery of new membrane to sites of active growth.
Previous studies have demonstrated that Rho3 and Cdc42
have direct roles in regulating exocytosis which are indepen-
dent of their role in regulating the polarity of the actin cy-
toskeleton (1, 2). Studies from a number of laboratories have
shown that a multisubunit vesicle tethering complex known as
the exocyst is likely to be a critical effector for Rho/Cdc42
signaling during polarized exocytosis (1, 2, 11, 22). A number
of models have been suggested to describe the action of Rho
GTPases in regulating exocytic function (28, 30). Analysis of
specific loss-of-function alleles of RHO3 and CDC42 demon-
strated that defects in secretion could be distinguished not only
from actin polarity but from the polarization of the exocytic
machinery as well. This led to the suggestion that Rho
GTPases act by local activation rather than recruitment of the
exocytic machinery (25).
Genetic analysis suggests that the pathway by which Cdc42
regulates secretion is closely linked to that of Rho3. Secretion-
defective alleles in each of these GTPases are suppressed by a
common set of genes, and the mutants exhibit synthetic lethal-
ity when combined in the same cell (1). Recent work has
provided direct evidence that the Exo70 subunit of the exocyst
both genetically and physically interacts with both Rho3 and
Cdc42 (29).
Although Rho3 and Cdc42 share a effector and have over-
lapping functions, there are different characteristics in how
these two proteins regulate exocytosis in yeast. Analysis of the
Rho3 and Cdc42 secretory mutants by electron microscopy and
secretory assays revealed that cdc42-6 mutants showed defects
only in cells with small or emerging buds; in contrast, rho3-V51
mutants exhibited secretory defects throughout bud growth (1,
2). These phenotypes suggested that the exocytic function of
Rho3 and Cdc42 is required at overlapping but distinct stages
of bud growth.
Most small GTPases require multiple elements to pro-
mote their association with the membrane on which they
engage their downstream targets (26). Modification of the
C-terminal CAAX motif by prenylation is common to both
Rho3 and Cdc42, with Rho3 predicted to be farnesylated
and Cdc42 shown to be geranylgeranylated (14, 17, 19).
However, as with other small GTPases, C-terminal prenyla-
tion by itself is not sufficient for stable membrane associa-
tion (10, 18). As with many other small GTPases, a second
site of interaction is thought to be required for both Rho3
and Cdc42 GTPases. Sequence alignment of Rho3 and
Cdc42 revealed that Rho3 has a long N-terminal extension,
which contains a site (a cysteine at position 5) for palmi-
toylation (24). In contrast, Cdc42 is not palmitoylated but
instead contains a polybasic domain adjacent to the CAAX
motif at its C terminus, which is thought to act as a mem-
brane targeting signal via the electrostatic interactions with
phospholipids at the plasma membrane (6, 12).
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In this study we examine how the function and localization
of two Rho GTPases are specified at distinct stages of polar-
ized growth in yeast. Using a novel monoclonal antibody, we
find that the pattern of cell surface localization observed for
the Rho3 GTPase is clearly distinct from that of Cdc42. Using
chimeric forms of these GTPases, we find that the N terminus
plays a particularly important role in this specification. The
functional effect imparted by the N terminus appears to have
two key elements. One element involves palmitoylation of a
cysteine in the N terminus of Rho3 that is critical in generating
the dispersed pattern of localization observed for Rho3. A
second element regulates the affinity of the GTPases for a
common effector, the exocyst complex. Taken together, this
work provides a model for how these GTPases have evolved
distinct functions by adopting sequence elements that affect
both the pattern of localization and the ability to engage the
downstream effector in a way that allows each GTPase to
function at different stages of polarized growth.
MATERIALS AND METHODS
Yeast strains, reagents, and genetic techniques. Yeast strains used in this study
are listed in Table 1. Standard methods were used for yeast media and genetic
manipulations. Cells were grown in YPD medium containing 1% Bacto-yeast
extract, 2% Bacto-peptone, and 2% glucose. The components of the medium
were from Fisher Scientific. Sorbitol, sodium azide (NaN3), sodium fluoride
(NaF), ethanolamine, -mercaptoethanol, Triton X-100, and HIS-select nickel
affinity gel were obtained from Sigma Chemical (St. Louis, MO). Zymolyase
(100T) was from Seikagaku (Tokyo, Japan). Tween 20 (10%) was from Bio-Rad.
Dithiothreitol (DTT), bovine serum albumin (BSA), yeast nitrogen base, raffin-
ose, galactose, and 5-fluoroorotic acid (5-FOA) were from US Biologicals
(Swampscott, MA). Glutathione-Sepharose beads were from Amersham Bio-
sciences. Secondary antibodies for the Odyssey Imaging system were from LI-
COR Biosciences and Molecular Probes. Secondary antibodies for immunoflu-
orescence were from Jackson ImmunoResearch. Formaldehyde (37%) was from
Electron Microscopy Sciences (Ft. Washington, PA). FluorSave reagent (mount-
ing medium) was from Calbiochem. Slides for immunofluorescence were from
Carlson Scientific, Inc. The bead beater for making yeast lysate was from Biospec
Products. Transformations for suppression analysis were performed using the
lithium acetate method described by Guthrie and Fink (9).
Plasmid construction. Plasmids used in this study are listed in Table 2. pB1366
TABLE 1. Yeast strains used in this study
Strain Genotype Reference
BY1426 MATa rho3::LEU2 ura3-52 his3-200 leu2-3,112 pRS316 RHO3 P. Brennwald collection
BY1595 MATa rho3::LEU2 ura3-52 his3-200 leu2-3,112 pRS313 RHO3 This study
BY1689 MATa rho3::LEU2 leu2-3,112 ura3-52 his3-200 pRS313 RHO3C5A This study
BY1718 MATa rho3::LEU2 leu2-3,112 ura3-52 his3-200 pRS313 RHO3A3,4 This study
BY1807 MATa cdc42::HIS3 ura3-52 leu2-3,112 pRS316 CDC42 P. Brennwald collection
BY1846 MATa cdc42::HIS3 ura3-52 his3-200 leu2-3,112 pRS315 CDC42NTR3A3,4 This study
BY2101 MATa rho3::LEU2 akr1::KanMX6 ura3-52 his3-200 leu2-3,112 pRS316 RHO3 This study
BY2102 MATa rho3::LEU2 erf2::KanMX6 ura3-52 his3-200 leu2-3,112 pRS316 RHO3 This study
BY2103 MATa rho3::LEU2 pfa4::KanMX6 ura3-52 his3-200 leu2-3,112 pRS316 RHO3 This study
BY2119 MATa rho3::LEU2 akr2::KanMX6 ura3-52 his3-200 leu2-3,112 pRS316 RHO3 This study
BY2120 MATa rho3::LEU2 swf1::KanMX6 ura3-52 his3-200 leu2-3,112 pRS316 RHO3 This study
BY2121 MATa rho3::LEU2 pfa3::KanMX6 ura3-52 his3-200 leu2-3,112 pRS316 RHO3 This study
BY2122 MATa rho3::LEU2 pfa5::KanMX6 ura3-52 his3-200 leu2-3,112 pRS316 RHO3 This study
BY2123 MATa cdc42::HIS3 akr1::KanMX6 trp1-63 ura3-52 his3-200 leu2- lys2-801 pRS316 CDC42 This study
BY2124 MATa cdc42::HIS3 akr2::KanMX6 trp1-63 ura3-52 his3-200 leu2- lys2-801 pRS316 CDC42 This study
BY2125 MATa cdc42::HIS3 erf2::KanMX6 trp1-63 ura3-52 his3-200 leu2- lys2-801 pRS316 CDC42 This study
BY2126 MATa cdc42::HIS3 swf1::KanMX6 trp1-63 ura3-52 his3-200 leu2- lys2-801 pRS316 CDC42 This study
BY2127 MATa cdc42::HIS3 pfa3::KanMX6 trp1-63 ura3-52 his3-200 leu2- lys2-801 pRS316 CDC42 This study
BY2128 MATa cdc42::HIS3 pfa4::KanMX6 trp1-63 ura3-52 his3-200 leu2- lys2-801 pRS316 CDC42 This study
BY2129 MATa cdc42::HIS3 pfa5::KanMX6 trp1-63 ura3-52 his3-200 leu2- lys2-801 pRS316 CDC42 This study
BY2232 MATa cdc42::HIS3 ura3-52 his3-200 leu2-3,112 pRS315 CDC42-NTRho3A17,18 This study
BY2233 MATa cdc42::HIS3 ura3-52 his3-200 leu2-3,112 pRS315 CDC42-NTRho3C5A This study
BY2234 MATa cdc42::HIS3 ura3-52 his3-200 leu2-3,112 pRS315 CDC42-NTRho3 This study
BY2236 MATa cdc42::HIS3 ura3-52 his3-200 leu2-3,112 pRS315 CDC42 This study
BY2486 MATa rho3::LEU2 ura3-52 his3-200 leu2-3,112 pRS316 rho3-NTC42 pRS313 CDC42-NTR3 This study
BY2487 MATa rho3::LEU2 ura3-52 his3-200 leu2-3,112 pRS316 rho3-A17,18 pRS313 CDC42-NTR3 This study
TABLE 2. Plasmids used in this study
Strain Host Plasmid description
BB442 BL21 pGEX4T1 SEC9 (aa 402 to 651)
BB1366 DH5 pRS313 RHO3
BB1367 DH5 pRS313 CDC42
BB1368 DH5 pRS313 rho3-NTC42
BB1516 XL1-Blue pRS313 RHO3-Q2
BB1590 DH5 pRS313 RHO3-A3,4
BB1515 XL1-Blue pRS313 RHO3-A5
BB1521 DH5 pRS313 rho3-A7-11
BB1592 DH5 pRS313 RHO3-A12-15
BB1591 DH5 pRS313 rho3-A16-19
BB1691 DH5 pRS313 rho3-A17,18
BB1369 DH5 pRS313 CDC42-NTR3
BB1483 DH5 pRS315 CDC42-NTR3
BB1522 DH5 pRS313 CDC42-NTR3Q2
BB1523 DH5 pRS313 CDC42-NTR3A5
BB1524 DH5 pRS313 CDC42-NTR3A7-11
BB1532 DH5 pRS315 CDC42-NTR3Q2
BB1533 DH5 pRS315 CDC42-NTR3A5
BB1534 DH5 pRS315 CDC42-NTR3A7-11
BB1587 BL21 pGEX6P1PH EXO70
BB1588 DH5 pRS313 CDC42-NTR3A16-19
BB1589 DH5 pRS313 CDC42-NTR3A12-15
BB1593 DH5 pRS315 CDC42-NTR3A12-15
BB1594 DH5 pRS313 CDC42-NTR3A3,4
BB1596 DH5 pRS315 CDC42-NTR3A3,4
BB1597 DH5 pRS315 CDC42-NTR3A16-19
BB1598 DH5 pRS313 CDC42-NTR3A17,18
BB1731 DH5 pRS315 CDC42
BB1857 DH5 pRS315 CDC42-NTR3A6
BB1964 DH5 pRS316 rho3-A17,18
5208 WU AND BRENNWALD MOL. CELL. BIOL.
(pRS313 RHO3) and pB1367(pRS313 CDC42) were generated by subcloning a
BglII and SalI fragment containing the entire open reading frame of RHO3 and
CDC42 as well as the 500-bp promoter region and 250-bp 5 untranslated region
(UTR) into the pRS313 vector. The resulting plasmids were then used as the
backbone for creating the RHO3-CDC42 chimera. Chimeric genes CDC42-NTR3
and rho3-NTC42 were constructed by overlapping PCRs and verified by DNA
sequencing (13, 31).
Protein purification and quantification. The pGEX-6P6H (pB1579) plasmid
was constructed as described previously (29). This vector was used to create the
following glutathione S-transferase (GST) fusion constructs: GST-Sec3 (amino
acids [aa] 1 to 319) and GST-Exo70 (aa 1 to 623). All constructs were confirmed
by sequencing, and protein expression was performed with Escherichia coli BL21
cells. Cells were grown at 37°C in terrific broth medium to an optical density at
599 nm (OD599) of 2.0 to 2.5. Cells were shifted to 25°C, and protein expression
was induced with 0.1 mM IPTG (isopropyl--D-thiogalactopyranoside) for 3 h at
25°C.
6His tag purification was performed by binding the bacterial lysate to HIS-
select nickel affinity gel (Sigma), followed by eluting the GST fusion proteins
with 500 mM imidazole. The 6His eluates were then incubated with glutathi-
one-Sepharose beads at 4°C for 1 h and then washed with wash buffer (20 mM
Tris, pH 7.5, 120 mM NaCl, and 1% Tween 20) to remove unbound proteins.
Protein concentration was determined by comparison to purified protein stan-
dards after SDS-PAGE and Coomassie blue staining. Quantification of Coomas-
sie blue-stained gels was performed with an Odyssey infrared imaging system
(LiCor).
Generation of yeast cell lysates. RHO3L74, rho3-NTC42L61, rho3-L74A17,18
CDC42-L61, and CDC42-NTR3L74 were amplified by PCR and subcloned be-
hind the GAL1 promoter in a LEU2 integrating vector (BB24, pRS305 with
GAL1 promoter). The vector was linearized by digesting with BstXI and trans-
formed into a wild-type Gal strain, BY17 (a GAL1 leu2-3,112 ura3-52). Yeast
strains were grown overnight in YP with 3% raffinose at 30°C to mid-log phase
with an OD599 of 1 to 1.5 and then induced with 1% galactose for 4 h at 30°C.
Cells were pelleted by centrifugation at 5,000 rpm for 5 min and washed with
double-distilled water (ddH2O). Pellets were immediately frozen on dry ice.
Frozen pellets were lysed with lysis buffer using a bead beater from Biospec
Products. The optimal wet weight for the small chamber was 5 to 6 g. The pellet
was beaten for 1 min followed by a 3-min pause for five cycles. The resulting
lysate was then subjected to centrifugation for 10 min at 17,000  g, followed by
ultracentrifugation at 100,000  g for 30 min. The protein concentration of the
lysate was measured by a Bradford assay. Each lysate was normalized to about 25
mg/ml total protein concentration and frozen on dry ice.
GST pulldown from yeast cell lysates. All recombinant proteins were present
at a final concentration of 3 M. Cell lysates for GST pulldown experiments were
prepared as described above and incubated with each fusion protein on gluta-
thione-Sepharose beads for 1.5 h at 4°C. The beads were washed five times with
lysis buffer (20 mM Tris-HCl, pH 7.5, 120 mM NaCl, 10 mM MgCl2, 1% Tween
20, 1 mM DTT) and boiled at 95°C for 5 min. Samples were subjected to
SDS-PAGE analysis and blotted with Rho3 and Cdc42 monoclonal antibodies.
Quantification of Western blots was performed with an Odyssey infrared imaging
system.
Antibodies. Monoclonal antibodies raised against GST-Rho3 and GST-Cdc42
were isolated and production cell culture supernatants generated in collabora-
tion with the University of North Carolina (UNC) Immunology Core facility.
Generation of affinity-purified rabbit polyclonal antibodies against Cdc42 was
described previously (1).
Immunofluorescence. Cells were grown overnight to mid-log phase and fixed
immediately with 37% formaldehyde. Fixed cells were spheroplasted, permeab-
ilized with 0.5% SDS, and affixed to the slides as described previously (5, 25).
Immunostaining was performed using a mouse monoclonal antibody against
Rho3 (monoclonal antibody [MAb] 4-51) at a 1:5 to 1:50 dilution of cell culture
supernatant and an affinity-purified rabbit polyclonal antibody against Cdc42 at
a 1:75 dilution. The mouse monoclonal antibody against Cdc42 (MAb28-10) was
used for immunofluorescence at a 1:25 to 1:50 dilution of cell culture superna-
tant. Rhodamine Red-X-AffiniPure goat anti-mouse IgG and fluorescein isothio-
cyanate (FITC)-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch
Laboratories, West Grove, PA) were used at a 1:50 dilution for detection of
Rho3 and Cdc42, respectively. Stained cells were viewed using a microscope
(model E600; Nikon) equipped with a 512- by 512-pixel back-illuminated frame
transfer charge-coupled-device camera (Princeton Instruments) and Metamorph
software (Universal Imaging Corp.). Approximately 200 cells were randomly
selected for quantitation. Small-budded cells were defined as cells with buds
smaller than half the size of the mother cell, and large-budded cells were defined
as cells with buds larger than half the size of the mother cell.
Subcellular fractionation. Wild-type cells containing rho3-NTC42, RHO3-
A3,4, RHO3-A5, and rho3-A17,18 (see Fig. 3E) or palmitoyltransferase deletion
strains containing wild-type RHO3 (see Fig. 5C) were grown overnight in selec-
tive media, harvested, and grown in rich medium for 2 h. Yeast cells (approxi-
mately 200 OD599 units) were washed with 10/20/20 buffer (10 mM Tris, pH 7.5,
20 mM NaN3, and 20 mM NaF) and spheroplasted in 7.2 ml of spheroplast buffer
(0.1 M Tris, 10 mM azide, 1.2 M sorbitol, and 21 mM -mercaptoethanol with
0.08 mg/ml Zymolyase 100T) for 30 min at 37°C. The spheroplasts were lysed in
5 ml of ice-cold triethanolamine (TEA)-sorbitol (10 mM TEA, pH 7.2, and 0.8
M sorbitol) with a protease inhibitor cocktail [1 mg/ml each of leupeptin, apro-
tinin, antipain, 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 20 mM pepstatin
A, and 2 mM 4-(2-aminoethyl)benzenesulfonyl fluoride] and spun at 450  g for
3 min in a cold centrifuge to remove unbroken cells. The lysates were spun at
30,000  g for 20 min at 4°C in a Sorvall centrifuge tube to separate the
supernatant and pellet fractions. All pellets were normalized to the volume of the
supernatant fractions. Equal volumes of total lysate and supernatant and pellet
fractions were boiled in SDS sample buffer, run on a 15% SDS-polyacrylamide
gel, and blotted with polyclonal Sso1/2 antibody (1:2,000), monoclonal Rho3
antibody (1:200), or Cdc42 antibody (1:250). Quantification of Western blots was
performed with an Odyssey infrared imaging system.
RESULTS
Rho3 and Cdc42 have distinct localization patterns on the
plasma membrane. The function of Cdc42 in polarized growth
is thought to be closely tied to its highly polarized pattern of
localization on the plasma membrane. Consistent with this
notion, we have previously shown that Cdc42 mutants defective
in exocytic function demonstrate this defect only during early
bud emergence, when the localization of Cdc42 is highly po-
larized, and not at later stages of bud growth. In contrast,
secretion-defective mutants in the Rho3 GTPase demonstrate
defects throughout bud growth. However, the intracellular lo-
calization of Rho3 at endogenous levels of expression has not
been described (see Discussion). We have isolated a new
monoclonal antibody to Rho3, which we have used in double-
labeling experiments to examine the pattern of localization
compared to that of Cdc42. The results, shown in Fig. 1, dem-
onstrate a surprisingly distinct staining pattern for Rho3. In
stark contrast to the tightly polarized localization of Cdc42,
Rho3 localizes along most of the plasma membrane and is only
slightly more abundant in the buds and bud-proximal portion
of the mother cell plasma membrane. This led us to hypothe-
size that the distinct plasma membrane localization patterns
for these two GTPases might be linked to their distinct func-
tions in promoting polarized growth during different stages of
bud growth.
To test this model, we created chimeric forms of the two
GTPases to identify the region(s) required for the distinct
functions and localization in the cell. Surprisingly, we found
that chimeras that exchanged a small region (19 residues of
Rho3 and 6 residues of Cdc42) at the extreme N termini of the
two proteins resulted in rather dramatic consequence to both
the function and localization of these two GTPases. We exam-
ined the functional consequences of these chimeras expressed
behind either the CDC42 or RHO3 promoter present on a
low-copy CEN plasmid. The ability of each chimera to com-
plement a deletion in the chromosomal copy of RHO3 or
CDC42 was assessed using a plasmid shuffle assay (see Mate-
rials and Methods). The results of the complementation show
that the N terminus of Rho3 is critical for its function (Fig. 2B).
Rho3, which has had its N terminus replaced with that of
Cdc42 (rho3-NTC42), no longer complements rho3, demon-
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strating that the N terminus of Rho3 is required for its essen-
tial function. Surprisingly, the addition of this region onto
Cdc42 converts Cdc42 into a protein, Cdc42-NTR3, that com-
pletely complements the loss of Rho3 in the cell. Interestingly,
the ability of the Cdc42-NTR3 chimera to act as the sole source
of Rho3 does not result in a diminution of its ability to act as
Cdc42. The Cdc42-NTR3 chimera shows no detectable loss of
function as the sole source of Cdc42, as it can completely
complement cdc42. Expression levels of the chimeras were
nearly identical to those of their nonchimeric genes (on CEN
plasmids), suggesting that the switch of function phenotype
was not due to the elevated protein levels in the cell. Identical
results were obtained for all constructs whether expressed be-
hind the CDC42 or RHO3 promoter (data not shown). Since
the CDC42-NTR3 chimeric gene was able to individually com-
plement rho3 and cdc42, we examined whether it could
simultaneously act as the sole source of both GTPases by
meiotic analysis of a cross between the two CDC42-NTR3-
complemented knockout strains. The result of this cross clearly
demonstrated that while the chimeric gene complemented the
individual rho3 and cdc42 deletions, it was unable to rescue the
segregants predicted to contain both rho3 and cdc42 deletions
(data not shown).
We then examined the effect of the N-terminal exchange on
the localization of the chimeric GTPases by immunofluores-
cence. Since the Rho3 and Cdc42 antibodies bind to the main
body of each GTPase and not to N-terminal domains ex-
changed in the chimeras, we could monitor the localization of
each chimera as the only source of either Rho3 or Cdc42 in the
cell. When we examined the staining pattern of Cdc42-NTR3
chimera as the sole source of Cdc42 in the cell, we found a
striking change in the staining pattern observed with the Cdc42
antibody. The staining pattern, seen in Fig. 2D, is very similar
to the dispersed plasma membrane localization of Rho3, and
more importantly, not only did this chimeric protein obtain a
“Rho3-like” staining pattern; a significant number of cells with
small or incipient buds also maintained a “Cdc42-like” staining
pattern. Quantitation of the observed staining patterns sug-
gested that roughly 80% of the small-budded cells acquired a
localization pattern that resembles both Rho3 and Cdc42.
When the Rho3-NTC42 chimera was analyzed, we found that
the normal Rho3 pattern of plasma membrane staining was
lost, and only diffuse cytoplasmic staining was observed. We
confirmed the change in plasma membrane localization of the
Cdc42-NTR3 chimera using a monoclonal antibody against
Cdc42. The results, shown in Fig. 2E, demonstrate that the
effect of the N terminus of Rho3 on Cdc42 localization is
clearly detected by both antibodies. Taken together, these re-
sults suggested that the Rho3 N terminus is an important
determinate for localization—both in dictating the pattern of
localization and in the recruitment of the Rho GTPase to the
plasma membrane. We believe that the ability of the Cdc42-
NTR3 chimera to adopt both “Rho3-like” and Cdc42-like pat-
terns of localization is important for its ability to function as
either GTPase in the cell. Therefore, the ability of the N
terminus to affect both the function and localization of the
associated GTPase gives strong support to the model that
localization pattern is critical to the function of these two Rho
GTPases in the cell.
The Rho3 N terminus encodes multiple determinants of
specificity. To further dissect the mechanism by which the N
terminus of Rho3 affected the function and localization of the
protein, we carried out an extensive mutagenesis of this do-
main and examined the effect on localization and function both
in the context of the Cdc42-NTR3 chimera and in that of
wild-type Rho3. The functional studies shown in Fig. 3B dem-
onstrate a requirement for a cysteine at position 5 and two
adjacent residues at positions 3 and 4 in the ability of this
domain to affect a switch of function phenotype in the context
of the Cdc42-NTR3 chimera. The cysteine residue at position
five has previously been shown to be palmitoylated (24). Con-
sistent with this notion, we find that the Rho3-C5A protein no
longer demonstrates plasma membrane staining, and the pro-
tein is largely absent from the membrane pellet fraction fol-
lowing cell fractionation (Fig. 3D and E). The effect of the
alanine mutations at position 3,4 (A3,4) (from phenylalanine
and leucine) appears to have a similar effect on localization
and fractionation (Fig. 3D and E) and therefore may be a
component of the recognition sequence used by the palmitoyl-
transferase.
We next examined the effect of the palmitoylation site mu-
FIG. 1. Localization of Rho3 and Cdc42. Localization of Rho3 and
Cdc42 was examined by immunofluorescence microscopy. Each cell
was double labeled with mouse anti-Rho3 monoclonal antibody (red
pseudocolor) and affinity-purified rabbit anti-Cdc42 polyclonal anti-
body (green pseudocolor) in a RHO3 plasmid shuffle strain. Cells
containing rho3D are used as a negative control for specificity of the
Rho3 monoclonal antibody. rho3 cells were kept alive by the presence
of the CDC42-NTR3 chimera. Cells were grown in selective media,
fixed, and processed for immunofluorescence microscopy as described
in Materials and Methods. Scale bar, 1 m.
5210 WU AND BRENNWALD MOL. CELL. BIOL.
tations on the ability of the N terminus of Rho3 to affect the
localization pattern of the Cdc42-NTR3 chimera. Interestingly,
we found that the cysteine-to-alanine mutation in this chimera
resulted in a nearly complete loss of the Rho3-like staining
pattern and instead revealed a staining pattern almost identical
to that seen for wild-type Cdc42. Thus, palmitoylation at the N
terminus of Rho3 appears to be a critical signal in redirecting
the pattern of localization from a highly polarized “Cdc42-
like” pattern to the more dispersed pattern seen for Rho3.
Unexpectedly, while loss of palmitoylation was required for
the switch-of-function phenotype, it was dispensable for func-
tion in the context of wild-type Rho3. Although these muta-
tions resulted in a significantly more soluble protein (as judged
by fluorescence and fractionation), presumably enough Rho3
is associated with the membrane to provide the minimal re-
quirements for Rho3 function.
Analysis of DHHC family palmitoyltransferases on Rho3
membrane localization. Protein palmitoylation is thought to be
carried out primarily by members of the DHHC family of
proteins (16, 18). Yeast contains seven members of the DHHC
family, one of which, Erf2, had previously been implicated in
palmitoylation of the Rho3 N terminus (24). While erf2 was
the only DHHC family member that resulted in a clear loss of
Rho3 palmitoylation, it was proposed that other DHHC family
members were likely to be involved as well, since loss of erf2
results in only a partial reduction in the palmitoylation of Rho3
(24).
Since palmitoylation of the N terminus is essential for the
Cdc42-NTR3 chimera to function as the sole source of Rho3,
this allowed us to ask whether a specific member(s) of
the DHHC family of palmitoyltransferases was required for
the Cdc42-NTR3 switch-of-function phenotype. To examine
FIG. 2. The N terminus of Rho3 is necessary and sufficient for its function and localization. (A) Schematic representations of RHO3, RHO3
with the N terminus of CDC42 (rho3-NTC42), CDC42, and CDC42 with the N terminus of RHO3 (CDC42-NTR3). (B) RHO3, rho3-NTC42, CDC42,
and CDC42-NTR3 were transformed into a RHO3 plasmid shuffle strain or a CDC42 plasmid shuffle strain on a CEN HIS3 plasmid. The growth
of three independent colonies was shown under restrictive conditions where the wild-type RHO3-URA3 or the CDC42-URA3 plasmid was lost by
counterselection on 5-FOA plates. (C) Whole-cell lysates were prepared of strains with CDC42 or CDC42-NTR3 as the only source for CDC42 and
strains with RHO3 or rho3-NTC42 as the only source for RHO3. Lysates were subjected to SDS-PAGE analysis and blotted with Cdc42 or Rho3
monoclonal antibodies. Since rho3-NTC42 cannot function as the only copy of RHO3 in the cell, the gain-of-function chimera CDC42-NTR3 was
introduced into the cell to maintain viability. (D) Cells containing plasmids encoding RHO3, rho3-NTC42, CDC42, and CDC42-NTR3 as the only
source of Rho3 or Cdc42 in the cell were grown at 25°C, fixed, and processed for immunofluorescence. Mouse monoclonal antibody against Rho3
and rabbit polyclonal antibody against Cdc42 were used as described in Materials and Methods. The yeast strains (BY2235, BY2486 [see Table
1]) contain rho3 complemented by CDC42-NTR3 in addition to the chimera shown to allow us to examine the localization of noncomplementing
forms of Rho3. The anti-Rho3 MAb does not recognize the Cdc42-NTR3 protein. (E) Cells containing CDC42 or CDC42-NTR3 as the only source
of CDC42 were grown at 25°C and processed for double-label immunofluorescence with affinity-purified rabbit polyclonal antibody and a mouse
monoclonal antibody, both against Cdc42. Scale bar, 2 m.
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this point further, we constructed strains containing deletions
of each of the seven DHHC family members in the context of
the RHO3 plasmid shuffle strain. We then examined the effect
of loss of each palmitoyltransferase on the ability of the CDC42-
NTR3 chimera to complement the rho3, following growth on
5-FOA medium. Surprisingly, we found that erf2, encoding a
palmitoyltransferase previously reported to be a significant source
of palmitoyltransferase activity on Rho3 (24), had only a modest
effect on the ability of the chimera to complement rho3. Loss of
another palmitoyltransferase, Pfa4, also showed a similar partial
effect on complementation. In contrast to the modest effect on
complementation in the presence of erf2 and pfa4, loss of the
Akr1 transferase was found to be essential for the switch of
function, as loss of this DHHC family member completely
FIG. 3. The N terminus of RHO3 contains two elements that are important for its function and localization. (A) Single residues or a group of
residues were mutated to alanine at the N terminus of Rho3. Mutations are depicted with colored boxes. (B) CDC42 and both RHO3 and the
CDC42-NTR3 chimera with the corresponding N-terminal mutants were transformed into a RHO3 plasmid shuffle strain on a CEN HIS3 plasmid.
The ability of the mutants to complement rho3 was analyzed on 5-FOA plates where the wild-type RHO3-URA3 plasmid is lost. (C) CDC42,
CDC42-NTR3, CDC42-NTR3A3,4, CDC42-NTR3A5, and CDC42-NTR3A17,18 were first transformed into a CDC42 plasmid shuffle strain and then
grown on 5-FOA plates to evict the original CDC42 plasmid. Immunofluorescence was performed using anti-Cdc42 polyclonal antibody as
described in Materials and Methods. (D) Yeast cells containing RHO3, rho3-NTC42, RHO3-A3,4, RHO3-A5, and rho3-A17,18 on CEN-HIS3
plasmids or an integrated copy of rho3-V51 (2) were grown to mid-log phase at 25°C, fixed, and processed for immunofluorescence using anti-Rho3
MAb5-41. Note the rho3-V51 mutant cells were grown in rich medium and hence are smaller. Scale bar: 2 m. (E) Yeast cells containing RHO3,
rho3-NTC42, RHO3-A3,4, RHO3-A5, and rho3-A17,18 as the only source of RHO3 were grown at 25°C, spheroplasted, lysed, and spun at 30,000 
g to separate the cytosolic and the membrane fraction. Samples of total cell lysates (total), supernatant (Sup, S30), and pellet (P30) were subjected
to SDS-PAGE analysis and Western blot analysis. rho3-NTC42 (BY2486) and rho3-A17,18 (BY2487) strains contain a CDC42-NTR3 on a CEN-HIS3
plasmid to maintain the viability of the cell.
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blocked the ability of CDC42-NTR3 to complement growth. De-
letion of the other four DHHC family members showed no de-
tectable effect on complementation of rho3 by CDC42-NTR3.
To determine if the effect caused by the loss of akr1 was due
to a change in the localization of the chimeric protein, we
examined the staining pattern of the Cdc42-NTR3 chimera as
the only source of Cdc42 in an akr1 background. The results
demonstrate that as in the C5A mutant form of this chimera,
the Cdc42-NTR3 GTPase, an akr1 background is found only
in the highly polarized staining pattern typical of Cdc42 and is
unable to adopt the “Rho3-like” staining pattern seen for this
chimera in wild-type cells (Fig. 4B). The staining pattern of this
chimera in the other six DHHC knockout strains showed no
significant difference from that seen in wild-type cells.
To further delineate the role of these palmitoyltransferases
in determining the localization of Rho3 in the cell, we exam-
ined the effects of deleting each of the DHHC proteins on the
association of Rho3 with membranes following subcellular
fractionation. The results, shown in Fig. 4C, demonstrate that
six of the seven DHHC deletion mutants—including erf2—
showed no significant loss of membrane association. However,
consistent with the genetic requirement for AKR1 described
above, the akr1 strain shows a significant (P  0.01) increase
in the fraction of Rho3 that was soluble after 30,000  g
centrifugation (Fig. 4C). It is important to note that although
the solubility of Rho3 has increased in the akr1 strain, there
is still more protein associated with the pellet than a in C5A
mutant (40% versus 8.3%), consistent with the notion that
multiple palmitoyltransferases are likely to be involved in
palmitoylating Rho3. Taken together, these data strongly sug-
FIG. 4. Akr1 is required for the membrane association of Rho3 and the switch of function and localization phenotype of Cdc42-NTR3.
(A) RHO3, CDC42, and CDC42-NTR3 were transformed into RHO3 plasmid shuffle strains in which each palmitoyltransferase was deleted. The
growth of three independent colonies was shown under restrictive conditions where the wild-type RHO3-URA3 plasmid was lost by counterselec-
tion on 5-FOA plates. (B) Wild-type (WT) cells or cells deleted for each palmitoyltransferase, bearing CDC42-NTR3 as the only source for CDC42,
were fixed and processed for immunofluorescence using anti-Cdc42 polyclonal antibody as described in Materials and Methods. Approximately 200
cells were randomly selected and scored for Cdc42-like bud tip localization in small-budded cells or Rho3-like dispersed plasma membrane
localization in small- and large-budded cells. The bar graphs represent the percentage of cells with either “Cdc42-like” localization or the
“Rho3-like” localization pattern. Quantitations were performed for four sets of immunofluorescence images, with error bars representing the
standard deviations. Wild-type or akr1 cells were grown at 25°C and processed for immunofluorescence with mouse monoclonal antibody against
Rho3. (C) Wild-type cells or cells deleted for each palmitoyltransferase were grown at 25°C, spheroplasted, lysed, and spun at 30,000  g to
separate the cytosolic and the membrane fraction. Equal volumes of total cell lysates (total) and supernatant (S30) and pellet (P30) fractions were
subjected to SDS-PAGE analysis and blotted with anti-Rho3 monoclonal antibody. As controls, the anti-Sso1/2 antibody and the anti-Adh1
antibody (Abcam Inc.) were used to detect the plasma membrane fraction (P30) and the cytosolic fraction (S30). The bar graph represents the
quantitation of results of three independent experiments. Data were analyzed by a two-tailed Student t test, with error bars representing standard
deviations.
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gest the involvement of a novel palmitoyltransferase, Akr1, in
palmitoylation of the N terminus of Rho3 and further demon-
strate the importance of N-terminal palmitoylation of Rho3 in
determining the distinct function and localization of Rho3 in
the cell.
The N-terminal region of Rho3 and Cdc42 determines the
strength of binding to Exo70. A second important element in
the Rho3 N terminus was identified by mutation of a pair of
basic residues at positions 17 and 18, arginine and lysine. When
these residues were replaced with alanine in the context of
either Rho3 or the Cdc42-NTR3 chimera, the ability of either
protein to rescue the loss of rho3 in the cell was completely
lost. When we examined the effect of these mutations on the
localization of Rho3 or Cdc42-NTR3, we found that the mutant
proteins localized similarly to the wild-type form of the pro-
teins (Fig. 3C and D), although there was a slight reduction in
the amount of Rho3 protein associated with the membrane
pellets by fractionation (Fig. 3E). The strong loss-of-function
phenotypes associated with mutations at these residues sug-
gested that they might play a role in the interaction of Rho3
with an upstream or downstream component of its signaling
pathway. Exo70 is a critical downstream effector for both Rho3
and Cdc42 signaling to the exocytic apparatus, and both pre-
nylated Rho3 and Cdc42 bind to Exo70 in a manner that is
both GTP and effector domain dependent (29). We made use
of this assay to examine the effects of the A17,18 mutations on
the ability of GTP-locked Rho3 (Rho3-L74) to bind to the
effector protein Exo70. The results, shown in Fig. 5A, demon-
strate that Exo70 binding to GTP-bound Rho3 is almost com-
pletely lost in the presence of the A17,18 mutations. By mod-
eling the structure of Rho3 based on the existing structure of
Cdc42 (20), it is apparent that Rho3 residues 17 and 18 are
FIG. 5. The N terminus of Rho3 and Cdc42 determines the affinity of their interaction with Exo70. (A) GST-Sec9 (aa 402 to 651; control) and
GST-Exo70 (full length) were purified from bacteria and immobilized on glutathione-Sepharose beads. Yeast lysates overexpressing GTP-bound
Rho3 (Rho3-L74) or GTP-bound Rho3-A17,18 (Rho3-A17,18, L74) were expressed behind a galactose-inducible promoter. The binding exper-
iments were performed as described in the text. The bar graph on the right panel represents the quantitation of the Western blot. Data were
analyzed by a two-tailed Student t test, with error bars representing standard deviations of results from four independent experiments. (B) Ho-
mology model for yeast Cdc42 in a slate blue cartoon representation. The model is based on the template of human Cdc42 (1GRN). The N
terminus, C terminus, and switch I region of Cdc42 are colored dark blue, red, and light pink, respectively. Residues 4 and 5 (leucine and lysine)
in Cdc42, which correspond to residues 17 and 18 (arginine and lysine) in Rho3, are represented as spheres in light green. Residue 38 (aspartic
acid) of Cdc42, which corresponds to residue 51 (glutamic acid) in Rho3, is represented as spheres in light pink. (C) Yeast lysates overexpressing
GTP-locked forms of Rho3, Cdc42, the gain-of-function chimera Cdc42-NTR3, and the loss-of-function chimera Rho3-NTC42 were expressed
behind a galactose-inducible promoter in yeast. Lysates obtained from these strains were used in the binding experiments. The input represents
1% binding. The bar graph below the gel represents the quantitation of the Western blots using the Odyssey infrared imaging system. Data were
analyzed by the two-tailed Student’s t test, with error bars representing standard deviations of results from five independent experiments.
(D) Lysates containing the indicated Rho GTPase were incubated with either control GST-Sec9 (aa 402 to 651) or GST-Sec3 (aa 1 to
319)-containing beads and analyzed as for panel A. (E) Yeast lysate was incubated with increasing concentrations of GST-Exo70 as indicated above
the blot. Samples were subjected to Western blot analysis using monoclonal antibodies against Rho3 and Cdc42. The predicted EC50 is indicated
at the right.
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likely to be in close proximity (10 to 12 Å) to the effector
domain in the active GTP-bound form of the protein (Fig. 5B).
Therefore, these residues in the N terminus of Rho3 likely
represent part of the binding surface used by Exo70 in its
interaction with the GTP-bound forms of Rho3.
To further examine whether the localization of Rho3 de-
pends on its ability to bind to its effectors, we made use of a
previously characterized effector domain mutant, rho3-V51,
which is defective in promoting exocytosis and has a signifi-
cantly reduced affinity for Exo70 (2, 29). Immunofluorescence
using monoclonal Rho3 antibody in this mutant revealed a
dispersed plasma membrane staining pattern similar to that for
wild-type Rho3. Combined with the similar result from the
rho3-A17,18 mutant, this suggests that the “Rho3-like” plasma
membrane localization pattern for Rho3 is likely to be inde-
pendent of effector binding.
These results suggested that in addition to the function of
the N terminus of Rho3 in determining its unique localization
pattern, this region likely has a role in providing elements
involved in binding to the downstream effector Exo70. We
therefore examined the effect of exchanging the N termini of
Rho3 and Cdc42 on the binding to Exo70. The results, shown
in Fig. 5C, demonstrate that the Rho3 N terminus promotes
the interaction with Exo70 relative to that of the homologous
region of Cdc42. In particular, the binding to GTP-locked
Rho3-NTC42 is significantly reduced relative to that of Rho3,
and the binding to GTP-locked Cdc42 is significantly improved
by the presence of the Rho3 N terminus. To examine the effect
of these regions on the relative affinity of each GTPase for
Exo70, we performed equilibrium binding assays over a large
range of concentrations of recombinant Exo70. The extent of
interaction with GTP-locked forms of Rho3, Cdc42, and each
of the N-terminal chimeras was monitored by quantitative
Western blot analysis as shown in Fig. 5E. The binding results
were used to estimate the 50% effective concentration
(EC50)—a measure of the apparent affinity observed between
each GTPase and Exo70 in this assay. These binding isotherms
demonstrate that the Rho3 has a significantly higher affinity for
Exo70, with its native N terminus, than for the N-terminal
domain of Cdc42 (7 M versus over 20 M) and that while the
EC50 for both Cdc42 and Cdc42-NT
R3 was too low to be
accurately estimated by this procedure, it was clear that at the
binding of Cdc42-NTR3 it was consistently higher than that
of Cdc42 in this assay. This demonstrates that the N terminus
of Rho3 plays an important role in determining the strength of
interaction between the Rho GTPase and its effector Exo70.
This may play an important role in allowing Rho3 to signal to
the exocyst complex during the more dispersed (i.e., less con-
centrated) polarized growth conditions present during isotro-
pic growth of larger-budded cells, where both the GTPase and
its effector are likely to be present in significantly more dilute
concentrations on the plasma membrane.
We also examined the ability of Rho3 and Cdc42 to interact
with another potential Rho effector within the exocyst com-
plex, Sec3, utilizing an assay identical to that described above
for Exo70. The N terminus of Sec3 (aa 1 to 319) has been
shown previously to bind to Rho1 and Cdc42 (8, 32), but
interaction with Rho3 has not been examined. We therefore
examined the ability of different forms of Rho3 and Cdc42 to
interact with GST-Sec3-NT (aa 1 to 319). The results, shown in
Fig. 5D, demonstrate the expected nucleotide-dependent in-
teraction with GTP-locked Cdc42 (Cdc42-L61) but not GDP-
Cdc42 (Cdc42-N17) and unexpectedly also demonstrate GTP-
dependent binding to activated Rho3 (Rho3-L74) but not
GDP-Rho3 (Rho3-N30). Interestingly, as with the interaction
with Exo70, we find that this interaction is significantly reduced
by the presence of the A17,18 mutations in activated Rho3 and
the interaction with activated Cdc42 is significantly enhanced
by the addition of the N terminus of Rho3. This suggests that
the switch of function phenotype of the Cdc42-NTR3 chimera
may involve recognition by multiple subunits of the exocyst by
increasing its avidity for interaction with both the Exo70 and
Sec3 components of the complex.
DISCUSSION
The pattern of plasma membrane localization for Rho/
Cdc42 GTPase family members is thought to play a critical role
in determining and maintaining cell polarity. Here, using yeast
as a model, we provide direct evidence that the plasma mem-
brane localization pattern of two Rho GTPases is critical for
each of their functions in promoting bud growth at distinct
times during the cell cycle. Using chimeric forms of Rho3 and
Cdc42, we demonstrate that the N-terminal domain of these
two GTPases defines both of these functions. We find that the
Rho3 pattern of localization is critical for its function in pro-
moting polarized exocytosis—especially in larger-budded cells
where Cdc42 polarity is lost. In particular, palmitoylation of
Rho3 at C5 in the N-terminal domain is required for adopting
its dispersed plasma membrane staining and for allowing a
pool of Cdc42 to enter into a “Rho3-like” localization pattern.
The precise mechanism by which palmitoylation of Rho3 is
linked to this pattern of plasma membrane localization is pres-
ently unknown. We find evidence that DHHC family palmi-
toyltransferases play a role in these events. Previous studies
implicated the Erf2 palmitoyltransferase in modification of
Rho3; however, significant levels of palmitoylation were still
detectable in erf2 strains (24). We have found that deletion of
the gene encoding this enzyme has only a minor effect on the
switch-of-function property associated with the Cdc42-NTR3
chimera. Therefore, other palmitoyltransferases likely play a
role in determining the dispersed plasma membrane localiza-
tion pattern seen for Rho3. One of the unexpected results of
this work was the finding that the Akr1 enzyme plays an es-
sential role in the localization of Rho3. The results of this work
are consistent with the notion that Akr1 directly palmitoylates
the N terminus of Rho3, since it is required for the ability of
the Cdc42-NTR3 chimera to function as Rho3, for the chimera
to switch localization to the “Rho3-like” pattern, and for the
normal levels of membrane association of Rho3 following sub-
cellular fraction.
A previous study (22) suggested that a small pool of Rho3
may sometimes be found in a bud tip localization pattern and
that this pattern could be enhanced by utilizing a cold-sensitive
allele of Rho3 with elongated buds. However, it is important to
note that this pattern was observed under conditions that were
significantly different from those we have employed in this
study. In particular, this previous study utilized both a strong
inducible promoter (GAL7), which would be expected to result
in Rho3 that is highly overexpressed, and mutant forms of
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Rho3 (Rho3-E129 and Rho3-E129, A131) predicted to alter
the nucleotide cycle of the protein. It is possible that either
overexpression or mutational change in Rho3 (or the combi-
nation) results in the partial bud tip localization observed in
this study. In the present study, all constructs examined were
expressed on single-copy (CEN) plasmids behind the native
RHO3 (or CDC42) promoter and did not contain mutations
predicted to affect the GTPase cycle. We also observed the
dispersed “Rho3-like” plasma membrane staining pattern with
multiple antibody probes. Wild-type Rho3 was detected with
the anti-Rho3 monoclonal antibody, while a strikingly similar
pattern was detected for the Cdc42-NTR3 chimera with both
polyclonal anti-Cdc42 antibody and a mouse monoclonal anti-
body for Cdc42 (Fig. 2E). Taken together, these results suggest
that the dispersed plasma membrane staining pattern repre-
sents the authentic localization for Rho3 in the cell when
expressed at normal levels.
In contrast to the consistently dispersed pattern of localiza-
tion found for Rho3, Cdc42 is tightly polarized to bud tips
during bud emergence; however, Cdc42 polarization is lost as
the bud enlarges. This pattern of localization appears to re-
quire a set of signals distinct from that of Rho3; these signals
are likely to reside in the C-terminal portion of the protein. In
addition to the C-terminal prenylation (CAAX) signal, a
stretch of five basic residues, known as a polybasic region, is
present at the C terminus of Cdc42. The pattern of localization
observed for Cdc42 closely mirrors the pattern observed for
many proteins which ride to the plasma membrane along with
polarized delivery of post-Golgi secretory vesicles. This list
includes Sec4, Sec2, Myo2, and most of the subunits of the
exocyst complex (4, 7). Consistent with this notion, Cdc42 has
itself been suggested to be associated with post-Golgi secretory
vesicles during cell fractionation (27), and its polarized local-
ization is rapidly lost with a block in polarized secretion (15,
32). The switch of function chimera, Cdc42-NTR3, appears to
have the ability to adopt both “Rho3-like” and “Cdc42-like”
patterns of localization. This suggests that the pathways that
mediate these two localization patterns operate independently
of each other. The effects of the palmitoylation site mutation
on the localization of Cdc42-NTR3 support this view, as we see
that the loss of Rho3 localization has no effect on the ability of
this protein to demonstrate normal Cdc42 localization.
Although Cdc42 is likely to arrive at the plasma membrane
of actively growing cells through association with secretory
vesicles, the mechanism by which Rho3 is delivered to the
plasma membrane is not known. In this light it is interesting to
note that the Akr1 enzyme has been localized to the Golgi
apparatus (23) and Erf2 has been reported to be present pri-
marily in the endoplasmic reticulum (3). This suggests that
palmitoylated Rho3 is likely to traffic from an intracellular
membrane before adopting its final dispersed pattern of local-
ization on the plasma membrane. Preliminary work from our
laboratory suggests that, unlike Cdc42 localization, Rho3 lo-
calization is unaffected by a block in Golgi apparatus-to-sur-
face trafficking and therefore likely utilizes a pathway which is
independent of the classical secretory pathway. This may in-
volve a mechanism(s) related to yeast Ras2, which also is
thought to be palmitoylated at intracellular membranes yet
adopts a dispersed plasma membrane localization independent
of the secretory pathway (16).
In addition to giving insight into two distinct mechanisms for
localization of Rho/Cdc42 GTPases, this work demonstrates
the importance of effector binding to the specific function of
these two GTPases in the cell. This is particularly evident for
Rho3, which appears to have evolved a relatively high-affinity
means for interacting with the Exo70 component of the exo-
cyst. Rho3 plays a critical role in promoting secretion in larger-
budded cells, where the exocyst effector complex is significantly
less concentrated than its highly polarized pattern in emerging
buds. Consequently, the local concentrations in which Rho3
must engage its target are likely to be considerably more dilute
at this point in bud growth than during the highly polarized
exocytic delivery that occurs during bud emergence. In con-
trast, Cdc42 appears to have evolved a lower-affinity means of
interacting with Exo70, which might have evolved to match the
very high local concentrations of both Cdc42 and the exocyst
during bud emergence. This lower-affinity interaction between
Cdc42 and Exo70 does not appear to be required, as we find no
evidence of polarity or cell shape problems in cells when the
higher-affinity Cdc42-NTR3 construct is present as the sole
source of Cdc42 (unpublished observation). For Rho3, how-
ever, the parallel result is not the case, as we find that the
Cdc42-NTR3A17,18 mutant is able to be properly localized as
Rho3 but cannot function as Rho3 due to a reduced affinity of
the GTPase for Exo70. Therefore, localization of an otherwise
fully functional Rho GTPase, by itself, is not sufficient to pro-
vide Rho3 function.
It is clear that the N terminus of Rho3 plays a very important
role in regulating its specific function in the cell. Remarkably,
it does this by both specifying a dispersed pattern of localiza-
tion on the plasma membrane and increasing the avidity of
binding to the downstream effector. Both properties of the N
terminus appear to play an important role in how Rho3 regu-
lates vesicle docking and fusion during isotropic growth of
large-budded cells. This is in contrast to how Cdc42 acts during
bud emergence, when a concentrated patch of Cdc42 and exo-
cyst complex helps to promote a high flux of exocytosis at
highly polarized bud tips. As the bud enlarges, both Cdc42 and
exocyst polarization are lost and Rho3 is left as the primary
regulator of exocyst-dependent docking and fusion events.
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